Former FDA Official Highlights Impact of Healthcare Cuts Under Trump

Dr. David Kessler, former FDA commissioner and chief science officer of the White House Covid-19 Task Force, shared concerns about the consequences of significant reductions to the Department of Health and Human Services (HHS) during President Donald Trump’s administration. These cuts severely weakened essential public health services and undermined leadership in medical and scientific fields, potentially affecting the nation’s ability to respond effectively to future health emergencies.

Kessler reflected on the dismissals of key medical advisors, including the removal of Trump’s longtime personal physician, Dr. Harold Bornstein, who played a vital role during health crises. He emphasized that these dismissals weren’t isolated but part of a broader effort to weaken expert guidance, leading to an erosion of the country’s healthcare resilience.

He explained that Trump’s systematic budget cuts to agencies like the CDC, FDA, and NIH—crucial for vaccine research, health policy, and outbreak response—dismantled critical infrastructure. This resulted in shortages of testing supplies and PPE at the onset of the COVID-19 pandemic, exposing vulnerabilities that could have been mitigated with stronger federal support.

Kessler warned that reduced investment in public health and research compromised the U.S.’s leadership in global health initiatives. The weakened infrastructure hindered progress in vaccine development and pandemic preparedness, with potential long-term effects not only for the U.S. but globally. He cautioned that these setbacks could diminish the country’s scientific influence for decades to come.